GREGORY RETZINGER, MD
Medical Practice in Cincinnati, OH
License number
Ohio 35-06-4628-R
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
231 Albert Sabin Way Department Of Pathology, Cincinnati, OH 45267
Phone
(513) 558-4500
(513) 558-2289 (Fax)
(513) 245-3617
(513) 475-7259 (Fax)
(513) 558-2289 (Fax)
(513) 245-3617
(513) 475-7259 (Fax)
Personal information
See more information about GREGORY RETZINGER at radaris.comName
Address
Phone
1216 Red Roan Dr, Loveland, OH 45140
2822 Eden Ave UNIT 3B, Cincinnati, OH 45219
1216 Red Roan Dr, Loveland, OH 45140
2822 Eden Ave, Cincinnati, OH 45219
616 Shadowlawn Ln, Loveland, OH 45140
Professional information
See more information about GREGORY RETZINGER at trustoria.com
Gregory Scott Retzinger, Cincinnati OH
Gregory Scott Retzinger, Cincinnati OH
Specialties:
Pathology, Anatomic Pathology & Clinical Pathology, Clinical Pathology/Laboratory Medicine
Work:
Academic Pathology Associates Inc.
231 Albert Sabin Way, Cincinnati, OH 45267
231 Albert Sabin Way, Cincinnati, OH 45267
Education:
University of Chicago (1983)
Gregory S Retzinger, Cincinnati OH
Gregory S Retzinger, Cincinnati OH
Specialties:
Pathologist
Address:
2830 Victory Pkwy, Cincinnati, OH 45206
231 Albert Sabin Way, Cincinnati, OH 45267
231 Albert Sabin Way, Cincinnati, OH 45267
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology)
Fibrinogen-Coated Liposomes
Fibrinogen-Coated Liposomes
US Patent:
5658588, Aug 19, 1997
Filed:
Mar 31, 1995
Appl. No.:
8/414368
Inventors:
Gregory Scott Retzinger - Cincinnati OH
Ashley P. Deanglis - Cincinnati OH
Ashley P. Deanglis - Cincinnati OH
Assignee:
University of Cincinnati - Cincinnati OH
International Classification:
A61K 9127
US Classification:
424450
Abstract:
A method for preparing fibrinogen-coated liposomes is disclosed. In this process, fibrinogen and an acylating agent are reacted in the presence of a dispersion of liposomes under specifically defined reaction conditions. The liposomes formed using this process, pharmaceutical compositions containing those liposomes, and the methods of clotting blood and delivering pharmaceutically-active agents and/or other chemicals utilizing those pharmaceutical compositions are also disclosed.